Article
Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers.
Indian journal of cancer - 1 Jan 2000
Bag A, Jyala N S, Bag N
Abstract excerpt
Phase I metabolic enzyme CYP1A1 plays an important role in xenobiotics metabolism and has been extensively studied as a cancer risk biomarker. CYP1A1 is polymorphic and its four variants, e.g., CYP1A1* 2 A, CYP1A1* 2C, CYP1A1* 3 and CYP1A1* 4 with trivial names m1, m2, m3, and m4 respectively, are most commonly studied for cancer link. Gene- gene interaction studies combining polymorphisms of this enzyme with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
